Pediatric dermatofibrosarcoma protuberans: Outcomes from a single institution - 08/03/26
Doi : 10.1016/j.jaad.2026.02.050
Kylee J.B. Kus, MD a, ⁎ 
, George Nassief, BA b, Timothy Orlowski, MD a, Christine Poblete-Lopez, MD a, Jennifer Lucas, MD, MHCM a, Jon G. Meine, MD a, Melissa E. McEnery-Stonelake, MD a, Allison T. Vidimos, RPh, MD a
, George Nassief, BA b, Timothy Orlowski, MD a, Christine Poblete-Lopez, MD a, Jennifer Lucas, MD, MHCM a, Jon G. Meine, MD a, Melissa E. McEnery-Stonelake, MD a, Allison T. Vidimos, RPh, MD a a Department of Dermatology, Cleveland Clinic Foundation, Cleveland, Ohio
b Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio
∗ Correspondence to: Kylee J.B. Kus, MD, Department of Dermatology, Cleveland Clinic Foundation, 2049 E 100th St, Cleveland, OH 44106 Department of Dermatology Cleveland Clinic Foundation 2049 E 100th St Cleveland OH 44106
En prensa. Pruebas corregidas por el autor.
Disponible en línea desde el Sunday 08 March 2026
Key words : dermatofibrosarcoma protuberans, dermatologic surgery, Mohs micrographic surgery, pediatrics
| Dr Kus and Author Nassief are co-first authors. |
|
| Funding sources: None. |
|
| Prior presentations: None. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: Approved by the Cleveland Clinic Institutional Review Board. |
© 2026
American Academy of Dermatology, Inc.. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?